Enveric Biosciences, Inc. (ENVB) bonds
ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.01 (-0.33%)
Close on Nov 13, 2026Market cap $6.78MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Enveric Biosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2017
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Enveric Biosciences's 10-K for the period ended Jun 23, 2020
| Issue | Amount issued |
|---|---|
| Second Note Amendment | $2.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?